Researchers from Singapore-MIT Alliance for Research and Technology have discovered a novel phage lysin – Abp013 – that displays great potential as an alternative antimicrobial agent against Gram-negative, multidrug-resistant bacteria.
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART)